ASX:IMEHealth Care Equipment & ServicesHealth Care Technology

ImExHS Ltd

IMEXHS Limited is an Australia-based provider of medical imaging software and radiology services in 18 countries, including Colombia, the United States and Australia.

—
+59.1%52-week return
Day Range
— – —
52 Week Range
$0.305 – $0.340
Volume
—
Avg Volume (10D)
5.56K
Market Cap
—
The company

The business

What ImExHS Ltd does

IMEXHS Limited is an Australia-based provider of medical imaging software and radiology services in 18 countries, including Colombia, the United States and Australia. The Company develops software-as-a-service imaging solutions that includes a Picture Archiving and Communications System (PACS), a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS). Its solutions are cloud-based, vendor neutral and zero footprint, with no need for installed software. Its radiology services provide radiological diagnostic services to hospitals and medical facilities in Colombia and Spain using IMEXHS medical imaging software. The Company's services business also provides it with medical images and radiologists interpretation and reports to develop artificial intelligence (AI) tools. Its solutions include AQUILA - Radiology, ALULA - Pathology, ANTEROS - cardiology, artificial intelligence and advanced visualization.

Incorporated
AUS
Public since
2005-12-14
Employees
290
Shareholders
738
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on ImExHS Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise IME based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.340+$0.000 (+0.00%)over 6M
Hi$0.340Lo$0.305
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
—
Prev Close
—
Day High
—
Day Low
—
52wk High
$0.340
52wk Low
$0.305

Valuation

Multiples
Market Cap
—
Shares Out
—
Price/Book
1.19

Trading Activity

Volume & book
Volume
—
Value Traded
—
Avg Vol 10D
5.56K

Performance

Total return
1 Day
+0.00%
5 Day
+12.90%
13 Week
+0.00%
52 Week
+59.09%
YTD
-12.50%
Peers & news

Latest news

From the Small Caps desk
IMEXHS wins $2m radiology contract with Colombia’s National Police
Technology

IMEXHS wins $2m radiology contract with Colombia’s National Police

A wholly-owned subsidiary of medical imaging company IMEXHS (ASX: IME) has secured a $2 million radiology contract with the National Police of Colombia. The win is reported to be IMEXHS’ largest contract to date. Subsidiary IMEXHS RIMAB will provide world-class radiology outsourcing services to approximately 48,000 patients at a new police hospital in Bogota using […]

Diagnostic imaging: which stock will become the next Pro Medicus?
Hot Topics

Diagnostic imaging: which stock will become the next Pro Medicus?

For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient. The underlying tech hasn’t really moved on since 1895, when […]

IMEXHS secures global partnership deal with Canon Medical Systems
Technology

IMEXHS secures global partnership deal with Canon Medical Systems

Medical imaging company IMEXHS (ASX: IME) signed a global partnership agreement with Vital Images, for its advanced visualisation software Vitrea, ahead of its half-year results, set to be published later this month. Earlier this month, IMEXHS received final device classification for its Hiruko Essential software suite in the US, which means it is clear to begin […]

ImExHS receives FDA exemption and plots course to commercialise US market
Biotechnology

ImExHS receives FDA exemption and plots course to commercialise US market

Medical imaging company ImExHS (ASX: IME) has received an operational boost with regards to its US operations after receiving final device classification for its Hiruko Essential software suite. The news means ImExHS now has the all-clear to commercialise its product in the US under the country’s Code of Federal Regulations (CFR). ImExHS says it will […]

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

✓Full broker research library
✓Complete CEO interview archive
✓IPO calendar and alerts
✓New research alerts
✓Mobile notifications
✓Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.